G G NomikosSummaryAffiliation: Eli Lilly and Company Country: USA Publications
| Collaborators
|
Detail Information
Publications
Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illnessG G Nomikos
Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, IN 46285 0510, USA
Behav Brain Res 113:97-103. 2000..These results may also contribute to unraveling the cellular basis of nicotine's association with neuropsychiatric disorders, thereby offering the prospect of new therapeutic advances for their treatment...
A role for cannabinoid CB1 receptors in mood and anxiety disordersJ M Witkin
Psychiatric Drug Discovery, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285 0510, USA
Behav Pharmacol 16:315-31. 2005....
The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamusE T Tzavara
Eli Lilly and Company, Lilly Corporate Center, Neuroscience Discovery Research, Indianapolis, IN 46285-0510, USA
Eur J Pharmacol 426:R3-4. 2001..This increase in norepinephrine outflow could play an important role in the pharmacological and potentially therapeutic actions of SR141716A...
Oral administration of the antiobesity drugs, sibutramine and rimonabant, increases acetylcholine efflux selectively in the medial prefrontal cortex of the ratR J Davis
Mol Psychiatry 13:240-1. 2008
